Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism
Introduction: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and/or pulmonary embolism (PE), is a common, acute, multifactorial disease with a five-years cumulative incidence of recurrence of approximately 25%. Actually, no single genetic defect can predict the risk of recurrence...
Main Authors: | Hossam Hodeib, Amira Youssef, Alzahraa A. Allam, Amal Selim, Mohamed A. Tawfik, Mohammed F. Abosamak, Ahmed Esam, Mohamed S. Abd Elghafar, Sameh Samir, Ola A. ELshora |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/6/874 |
Similar Items
-
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
by: Walter Ageno, et al.
Published: (2021-02-01) -
Predicting Recurrence after a First Unprovoked Venous Thromboembolism: Retrospective Validation of the DAMOVES Score
by: A. I. Franco Moreno, et al.
Published: (2018-07-01) -
Does aspirin have a role in preventing unprovoked recurrent thromboembolism?
by: Yenny Yenny
Published: (2015-12-01) -
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol
by: Faizan Khan, et al.
Published: (2019-10-01) -
Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
by: Amaia Iñurrieta, et al.
Published: (2018-10-01)